Skip to Main Content

Paper Details

Genomic and biological study of fusion genes as resistance mechanisms to EGFR inhibitors.
Nat Commun
6
2022
EGFR, EGFR mutant cell lines, EGFR mutant lung cancer, EGFR mutant non-small, EGFR tyrosine kinase, fusion genes, fusion oncogenes, gene fusions, imparting, patients, resistance-causing fusion oncogene, tyrosine
Author NameAffiliation
Michael Y TolstorukovDana-Farber Cancer Institute
Michael Y TolstorukovDana-Farber Cancer Institute
Pasi A J??nneDana-Farber Cancer Institute and Harvard Medical School
Pasi A J??nneLowe Center for Thoracic Oncology, Dana-Farber Cancer Institute
Pasi A J??nneBelfer Center for Applied Cancer Science, Dana-Farber Cancer Institute
  • 1 - 5

Datasets

Release 1.2